Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal. The Danish pharma ...

Abstract: This manuscript focuses on effective modulation techniques that enable the extension of soft-switching operations for a three-phase three-level dual active bridge under light-load conditions ...

Founded in 1976, Indah Kiat Pulp & Paper TBK is one of Indonesia’s leading pulp, paper and tissue producers. As part of Asia Pulp & Paper, one of the world’s largest pulp and paper manufacturers, the ...